
Nafgal30 gm
Navana Pharmaceuticals Ltd.
Naftifine Hydrochloride is a topical allylamine antifungal indicated for the treatment of superficial fungal skin infections.
Naftifine Hydrochloride is a topical allylamine antifungal indicated for the treatment of superficial fungal skin infections.
Naftifine Hydrochloride also demonstrates fungistatic activity against some Candida species in vitro; however, it is not FDA-approved for treatment of candidal skin infections and should not be relied upon for that purpose.
Dosing of Naftifine Hydrochloride depends on the strength and formulation used. For external/topical use only.
| Strength/Form | Indication | Frequency | Duration |
|---|---|---|---|
| 1% Cream/Gel | Tinea pedis, tinea cruris, tinea corporis | Twice daily | Up to 4 weeks |
| 2% Cream/Gel | Interdigital tinea pedis | Once daily | 2 weeks |
| 2% Cream | Tinea cruris, tinea corporis | Once daily | 2 weeks |
Apply a thin layer to cover the affected area and immediate surrounding skin. Do not use occlusive dressings unless directed by a physician.
Adverse reactions to Naftifine Hydrochloride are generally mild and localized to the application site.
Discontinue use and consult a physician if irritation or signs of sensitization develop (see Precautions and Warnings).
Naftifine Hydrochloride is contraindicated in patients with known hypersensitivity to naftifine hydrochloride or to any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.